Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention

被引:76
|
作者
Patel, Rupa R. [1 ]
Mena, Leandro [2 ]
Nunn, Amy [3 ]
McBride, Timothy [4 ,5 ]
Harrison, Laura C. [1 ]
Oldenburg, Catherine E. [6 ]
Liu, Jingxia [7 ]
Mayer, Kenneth H. [8 ,9 ,10 ]
Chan, Philip A. [11 ]
机构
[1] Washington Univ St Louis, Div Infect Dis, St Louis, MO 63130 USA
[2] Univ Mississippi, Med Ctr, Div Infect Dis, Jackson, MS 39216 USA
[3] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI USA
[4] Washington Univ St Louis, Brown Sch, St Louis, MO USA
[5] Washington Univ St Louis, Ctr Hlth Econ & Policy, St Louis, MO USA
[6] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA
[7] Washington Univ St Louis, Div Publ Hlth Sci, St Louis, MO USA
[8] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA
[9] Harvard Med Sch, Dept Med, Boston, MA USA
[10] Fenway Hlth, Fenway Inst, Boston, MA USA
[11] Brown Univ, Div Infect Dis, Providence, RI 02912 USA
来源
PLOS ONE | 2017年 / 12卷 / 05期
基金
美国国家卫生研究院;
关键词
MEDICAID; CARE; ACCESS;
D O I
10.1371/journal.pone.0178737
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pre-exposure prophylaxis (PrEP) can reduce U.S. HIV incidence. We assessed insurance coverage and its association with PrEP utilization. We reviewed patient data at three PrEP clinics (Jackson, Mississippi; St. Louis, Missouri; Providence, Rhode Island) from 2014-2015. The outcome, PrEP utilization, was defined as patient PrEP use at three months. Multivariable logistic regression was performed to determine the association between insurance coverage and PrEP utilization. Of 201 patients (Jackson: 34%; St. Louis: 28%; Providence: 28%), 91% were male, 51% were White, median age was 29 years, and 21% were uninsured; 82% of patients reported taking PrEP at three months. Insurance coverage was significantly associated with PrEP utilization. After adjusting for Medicaid-expansion and individual socio-demographics, insured patients were four times as likely to use PrEP services compared to the uninsured (OR: 4.49, 95% CI: 1.68-12.01; p = 0.003). Disparities in insurance coverage are important considerations in implementation programs and may impede PrEP utilization.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] PRE-EXPOSURE PROPHYLAXIS FOR HIV PREVENTION
    Cremin, I.
    Hallett, T.
    Dybul, M.
    Piot, P.
    Garnett, G.
    SEXUALLY TRANSMITTED INFECTIONS, 2011, 87 : A36 - A36
  • [2] Pre-exposure prophylaxis as HIV prevention in the UK
    Brady, Michael
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (03) : 150 - 152
  • [3] HIV prevention using pre-exposure prophylaxis
    Daou, S.
    Calmy, A.
    REVUE DE MEDECINE INTERNE, 2011, 32 (11): : 658 - 662
  • [4] Oral pre-exposure prophylaxis for HIV prevention
    Garcia-Lerma, J. Gerardo
    Paxton, Lynn
    Kilmarx, Peter H.
    Heneine, Walid
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (02) : 74 - 81
  • [5] PrEP: pre-exposure prophylaxis for HIV prevention
    Page, Matthew
    Nicholls, Jane
    TRENDS IN UROLOGY & MENS HEALTH, 2018, 9 (04) : 22 - 24
  • [6] Pre-exposure prophylaxis for prevention of HIV infection
    Lee, Joseph Wei En
    Lim, Sze Wern
    Choy, Chiaw Yee
    Wong, Chen Seong
    SINGAPORE MEDICAL JOURNAL, 2023, 64 (10) : 624 - 628
  • [7] What is the Place of Pre-Exposure Prophylaxis in HIV Prevention?
    De Man, Jeroen
    Colebunders, Robert
    Florence, Eric
    Laga, Marie
    Kenyon, Christopher
    AIDS REVIEWS, 2013, 15 (02) : 102 - 111
  • [8] Rethinking HIV pre-exposure prophylaxis prevention strategy
    Kistan, Jesne
    Serwadda, David
    LANCET HIV, 2016, 3 (04): : E155 - E157
  • [9] CDC promotes pre-exposure prophylaxis for HIV prevention
    Roehr, Bob
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [10] Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns
    Raymond A. Tetteh
    Barbara A. Yankey
    Edmund T. Nartey
    Margaret Lartey
    Hubert G. M. Leufkens
    Alexander N. O. Dodoo
    Drug Safety, 2017, 40 : 273 - 283